Item 5. Other Information
ITEM
5. OTHER INFORMATION
None.
Item
6. Exhibits
(d)
Exhibits:
Exhibit
Description
2.1
Agreement and Plan of Merger dated as of August 29, 2021, by and among Petra Acquisition Inc., Petra Acquisition Merger Inc. and Revelation Biosciences, Inc.
3.1
Certificate of Incorporation(2)
3.2
Second
Amended and Restated Certificate of Incorporation(1)
3.1
Amendment to the Second Amended and Restated Certificate of Incorporation of Petra Acquisition Inc., dated October 8, 2021
3.2
Certificate of Correction to the Amendment to the Second Amended and Restated Certificate of Incorporation of Petra Acquisition, Inc.
3.3
Amended and Restated Bylaws
4.1
Specimen
Unit Certificate.(2)
4.2
Specimen
Common Stock Certificate.(2)
4.3
Specimen
Warrant Certificate.(2)
4.4
Warrant
Agreement, dated October 7, 2020, between Continental Stock Transfer & Trust Company and the Company(1)
4.5
Description
of Registrant’s Securities.(3)
10.1
Investment
Management Trust Agreement, dated October 7, 2020, between Continental Stock Transfer & Trust Company and the Company.(1)
10.2
Escrow
Agreement, dated October 7, 2020, by and among the Company, Continental Stock Transfer & Trust Company and the Company’s
Initial Stockholders.(1)
10.3
Registration
Rights Agreement, dated October 7, 2020, between the Company and Investors.(1)
10.4
Subscription
Agreement, dated October 7, 2020, between the Company and Petra Investment Holdings LLC(1)
10.5
Business
Combination Marketing Agreement, dated October 7, 2020, by and among the Company, LifeSci Capital LLC, Ladenburg Thalmann & Co.
Inc., Northland Securities, Inc., and Ingalls & Snyder LLC(1)
10.6
Form
of Letter Agreement from each of the Registrant’s initial shareholders, officers and directors.(3)
10.7
Engagement Letter Agreement dated November 3, 2020 by and between the Registrant and LifeSci Capital LLC.
10.8
Amendment, dated September 17, 2021, to the Engagement Letter Agreement dated November 3, 2020 by and between the Registrant and LifeSci Capital LLC
10.9
Engagement Letter Agreement dated November 3, 2020 by and between the Registrant and LifeSci Capital LLC.
10.10
Promissory Note dated September 17, 2021 from the Registrant to Pine Valley Investments LLC
10.11
Note Cancellation Agreement by and between the Registrant and Pine Valley Investments, LLC
10.12
Promissory Note, dated as of October 13, 2021 from the Registrant to T3 Investments, LLC
10.13
Promissory Note, dated as of October 13, 2021 from the Registrant to Miro Kesic
10.14
Promissory Note, dated as of October 13, 2021 from the Registrant to Jared Solomon
14
Code
of Ethics.(2)
31.1*
Certification
of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
31.2*
Certification
of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section
302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification
of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
32.2**
Certification
of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
101.INS*
Inline XBRL Instance Document
101.CAL*
Inline XBRL Taxonomy Extension Calculation
Linkbase Document
101.SCH*
Inline XBRL Taxonomy Extension Schema Document
101.DEF*
Inline XBRL Taxonomy Extension Definition
Linkbase Document
101.LAB*
Inline XBRL Taxonomy Extension Labels Linkbase
Document
101.PRE*
Inline XBRL Taxonomy Extension Presentation
Linkbase Document
104
Cover Page Interactive Data File (embedded
within the Inline XBRL document)
(1)
Previously
filed as an exhibit to our Current Report on Form 8-K filed on October 13, 2020.
(2)
Previously
filed as an exhibit to our Form S-1, filed on September 21, 2020
(3)
Previously
filed as an exhibit to our Form 10-K, filed on March 31, 2021
*
Filed
herewith.
**
Furnished.
22
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
PETRA
ACQUISITION, INC.
Date: October 29,
2021
By:
/s/
Andreas Typaldos
Andreas
Typaldos,
Chief Executive Officer
( Principal Executive Officer )
Date:
October 29, 2021
By:
/s/
Sean Fitzpatrick
Sean
Fitzpatrick,
Chief Financial Officer
(Principal Financial and Accounting Officer )
23
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.